Repurposing drugs for treatment of SARS-CoV-2 infection: computational design insights into mechanisms of action S Kandwal, D Fayne Journal of Biomolecular Structure and Dynamics 40 (3), 1316-1330, 2022 | 20 | 2022 |
Genetic conservation across SARS-CoV-2 non-structural proteins–Insights into possible targets for treatment of future viral outbreaks S Kandwal, D Fayne Virology 581, 97-115, 2023 | 6 | 2023 |
DataPype: a fully automated unified software platform for computer-aided drug design MF Khan, S Kandwal, D Fayne ACS omega 8 (42), 39468-39480, 2023 | 2 | 2023 |
Antiproliferative and Tubulin-Destabilising Effects of 3-(Prop-1-en-2-yl) azetidin-2-Ones and Related Compounds in MCF-7 and MDA-MB-231 Breast Cancer Cells S Wang, AM Malebari, TF Greene, S Kandwal, D Fayne, SM Nathwani, ... Pharmaceuticals 16 (7), 1000, 2023 | 1 | 2023 |
Respiratory syncytial virus NS1 inhibits anti-viral Interferon-α-induced JAK/STAT signaling, by limiting the nuclear translocation of STAT1 C Efstathiou, Y Zhang, S Kandwal, D Fayne, EJ Molloy, NJ Stevenson Frontiers in Immunology 15, 1395809, 2024 | | 2024 |
Synthesis and Pro-Apoptotic Effects of Nitrovinylanthracenes and Related Compounds in Chronic Lymphocytic Leukaemia (CLL) and Burkitt’s Lymphoma AJ Byrne, SA Bright, JP McKeown, A Bergin, B Twamley, AM McElligott, ... Molecules 28 (24), 8095, 2023 | | 2023 |
Targeting conserved protein binding sites on SARS-CoV-2: nsp3 case study S Kandwal, D Fayne MDPI, 2023 | | 2023 |